Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 17,424 | 16,194 | 16,366 | 16,209 | 47,090 |
| Cost of Goods | 2,145 | 3,246 | 1,675 | 2,491 | 3,474 |
| Gross Profit | 15,279 | 12,948 | 14,691 | 13,718 | 43,616 |
| Operating Expenses | 44,951 | 47,581 | 47,533 | 42,549 | 40,116 |
| Operating Income | -29,527 | -34,387 | -32,167 | -28,340 | 3,974 |
| Interest Expense | 3,011 | 3,011 | 3,011 | 3,013 | 3,014 |
| Other Income | 2,866 | 2,746 | 8,179 | 27,230 | 1,832 |
| Pre-tax Income | -29,672 | -34,652 | -26,999 | -4,123 | 2,792 |
| Net Income Continuous | -29,672 | -34,652 | -26,999 | -4,123 | 2,792 |
| Net Income | $-29,672 | $-34,652 | $-26,999 | $-4,123 | $2,792 |
| EPS Basic Total Ops | -0.54 | -0.62 | -0.48 | -0.07 | 0.04 |
| EPS Basic Continuous Ops | -0.54 | -0.62 | -0.48 | -0.07 | 0.05 |
| EPS Diluted Total Ops | -0.54 | -0.62 | -0.48 | -0.07 | 0.14 |
| EPS Diluted Continuous Ops | -0.54 | -0.62 | -0.48 | -0.07 | 0.19 |
| EBITDA(a) | $-25,647 | $-30,452 | $-28,336 | $-24,482 | $7,890 |